Neuropathix Stock Price, News & Analysis

NPTX OTC

Company Description

Neuropathix (OTC: NPTX) is a publicly traded software and other prerecorded compact disc, tape, and record reproducing company in the Manufacturing sector.

NPTX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of NPTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

93.8M

Shares outstanding

Neuropathix (NPTX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

May 25, 2022

+8.33%

Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS

April 13, 2022

+19.94%

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

clinical trial

April 6, 2022

+0.25%

Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding

January 25, 2022

+5.49%

Neuropathix, Inc. Welcomes Daniele Piomelli, PhD, MD to the Company’s Scientific Advisory Board

management

January 18, 2022

+2.60%

Neuropathix, Inc. Receives Patent Grant from India for Its Novel Anti-Inflammatory Compounds

November 17, 2021

+38.94%

Neuropathix, Inc. Chooses Purisys for Process Optimization and Scale Up of Its Lead Drug Candidate KLS-13019

Neuropathix has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, management. View all NPTX news →

SEC Filings

View All

No SEC filings available for NPTX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NPTX Company Profile & Sector Positioning

Neuropathix (NPTX) operates in the Software and Other Prerecorded Compact Disc, Tape, and Record Reproducing industry within the broader Manufacturing sector and is listed on the OTC.